[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335991-105":59,"doc-detail-335991-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","integrative-analysis-confirms-tpx2-as-a-novel-biomarker-for-clinical-implication-tumor-microenvironment-and-immunotherapy-response-across-human-solid-tumors","Integrative analysis confirms TPX2 as a novel biomarker for clinical implication - tumor microenvironment, and immunotherapy response across human solid tumors","","Targeting Protein for Xenopus Kinesin Like Protein 2 (TPX2) functions as a microtubule-associated protein in spindle assembly and tumorigenesis. The study evaluates TPX2’s prognostic and immunological roles across pan-cancer using TCGA, TISCH, and HPA, with TPX2 expression linked to diagnostic and prognostic performance. Genomic alterations are analyzed via cBioPortal and validated with in vitro work in lung adenocarcinoma. TPX2 is elevated in 22 cancer types, correlating positively with CNV and negatively with methylation, and predicts worse outcomes in most cancers.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/integrative-analysis-confirms-tpx2-as-a-novel-biomarker-for-clinical-implication-tumor-microenvironment-and-immunotherapy-response-across-human-solid-tumors/335991/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/integrative-analysis-confirms-tpx2-as-a-novel-biomarker-for-clinical-implication-tumor-microenvironment-and-immunotherapy-response-across-human-solid-tumors/335991.png","ImageObject",300,407,{"name":92,"@type":93},"Anda","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main objective regarding TPX2 in this study?","Question",{"text":112,"@type":113},"To determine TPX2’s prognostic and immunological roles across pan-cancer and assess its clinical relevance for diagnosis, prognosis, and immunotherapy response.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which bioinformatics resources were used to analyze TPX2 across cancers?",{"text":117,"@type":113},"The TCGA database was used for comprehensive expression profiling, while TISCH and the Human Protein Atlas (HPA) supported expression and immune-related analyses. Genomic alterations were assessed with cBioPortal.",{"name":119,"@type":110,"acceptedAnswer":120},"How did TPX2 relate to tumor microenvironment and immunotherapy sensitivity?",{"text":121,"@type":113},"TPX2 expression showed significant associations with tumor microenvironment components (stromal and immune cells) and immune-related genes. Drug sensitivity analysis indicated TPX2 could predict response to chemotherapy and immunotherapy.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},335991,1791085434,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},962075006959,"https://ap-avatar.wpscdn.com/avatar/e0002397efbe92a78e?_k=1776741047341049297","[www.aging-us.com](www.aging-us.com) AGING 2024, Vol. 16, No. 3  \nResearch Paper  \nIntegrative analysis confirms TPX2 as a novel biomarker for clinical implication, tumor microenvironment, and immunotherapy response across human solid tumors  \nMingxia Zhu1,*, Xiaping Wang2,*, Qing Zhang3,*, Chen Xie4, Tongshan Wang5, Kai Shen5, Lan Zhang6, Xin Zhou5  \n1 Department of Radiation Oncology, The First Affiliated Hospital of Soochow University, Suzhou 215006, China 2 Department of Pathology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing 210000, China 3 Department of Neurosurgery, Xinghua People’s Hospital, Xinghua 225700, China  \n4 Department of Gastroenterology, The First Affiliated Hospital of Soochow University, Suzhou 215006, China 5 Department of Oncology, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China 6 Department of Radiation Oncology, Shanghai Tenth People’s Hospital of Tongji University, Shanghai 200072, China  \n*Equal contribution  \nCorrespondence to: Kai Shen, Lan Zhang, Xin Zhou; email: [shenkai@jsph.org.cn](shenkai@jsph.org.cn); [zhanglan246@163.com](zhanglan246@163.com), [https://orcid.org/0000-0002-9894-6739](https://orcid.org/0000-0002-9894-6739); [zhouxin5523@jsph.org.cn](zhouxin5523@jsph.org.cn)  \n[Keywords:](Keywords: TPX2)[ TPX2](Keywords: TPX2), pan-cancer, single-cell RNA-Seq, prognosis, immunotherapy  \nReceived: June 27, 2023 Accepted: December 1, 2023 Published: February 2, 2024  \nCopyright: © 2024 Zhu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.  \nABSTRACT  \nTargeting Protein for Xenopus Kinesin Like Protein 2 (TPX2) serves as a microtubule associated protein for the regulation of spindle assembly and tumorigenesis. We aim to investigate the prognostic and immunological role of TPX2 in pan-cancer. TCGA database, Tumor Immune Single-cell Hub (TISCH), and Human Protein Atlas (HPA) were retrieved to evaluate the expression pattern of TPX2 as well as its diagnostic and prognostic value in solid tumors. Genomic alterations of TPX2 were assessed with cBioPortal database. In vitro experiments in lung adenocarcinoma (LUAD) were performed to confirm the potential role of TPX2. Overexpression of TPX2 was found in 22 types of cancers, and was positively related with copy number variations (CNV) and negative with methylation. Up-regulated TPX2 could predict worse outcomes in the majority of cancers. Single-cell analysis revealed that TPX2 was mainly distributed in malignant cells (especially in glioma) and proliferating T cells. Genomic alteration of TPX2 was common in different types of tumors, while with prognostic value in two types of cancers. Additionally, significant correlations were found between TPX2 expression and tumor microenvironment (including stromal cells and immune cells) as well as immune related genes across cancer types. Drug sensitivity analysis revealed that TPX2 could predict response to chemotherapy and immunotherapy. Functional analyses demonstrated close relationship of TPX2 with immune function and malignant phenotypes. Finally, it was confirmed that knockdown of TPX2 could reduce proliferation and migration ability of LUAD cells. In summary, TPX2 could serve as a diagnostic and prognostic biomarker and a potential immunotherapy marker.  \nINTRODUCTION  \nTargeting Protein for Xenopus Kinesin Like Protein 2 (TPX2) acts as a microtubule-associated protein involved  \nin mitotic spindle assembly, primarily by activating the cell cycle kinase protein Aurora A [1] . Overexpression of TPX2 can cause centrosome amplification, leading to DNA polyploidy and facilitating tumorigenesis [2, 3] .  \nExtensive studies have revealed that TPX2 is upregulated and related to poor prognosis in multiple solid tumors, such as breast cancer and hepatocellul","cbCaimBETpbCWky6","https://ap.wps.com/l/cbCaimBETpbCWky6","pdf",6063580,28,"English","# Abstract\n# Introduction\n# Results\n## TPX2 gene expression and diagnostic value in pan-cancer","[{\"question\":\"What was the main objective regarding TPX2 in this study?\",\"answer\":\"To determine TPX2’s prognostic and immunological roles across pan-cancer and assess its clinical relevance for diagnosis, prognosis, and immunotherapy response.\"},{\"question\":\"Which bioinformatics resources were used to analyze TPX2 across cancers?\",\"answer\":\"The TCGA database was used for comprehensive expression profiling, while TISCH and the Human Protein Atlas (HPA) supported expression and immune-related analyses. Genomic alterations were assessed with cBioPortal.\"},{\"question\":\"How did TPX2 relate to tumor microenvironment and immunotherapy sensitivity?\",\"answer\":\"TPX2 expression showed significant associations with tumor microenvironment components (stromal and immune cells) and immune-related genes. Drug sensitivity analysis indicated TPX2 could predict response to chemotherapy and immunotherapy.\"}]","Integrative analysis confirms TPX2 as a novel biomarker for clinical implication - tumor microenvironment, and immunotherapy response across human solid tumors | PDF",1790013073,71]